Position in JNJ
as of Jun 30, 2026
· filed Jul 1, 2026
Position Value
$65,566,926
+$2,460,341 QoQ
Shares Held
258,168
0.0% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
4.56%
of 13F equity value
Holder Rank
#392
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CACTI ASSET MANAGEMENT LLC holds $154,335,418 across 7 Drug Manufacturers - General names. JNJ ranks #2 (42.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
645,299 | $82,920,921 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
258,168 | $65,566,926 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
36,450 | $2,100,249 | |
| 4 | PFE |
Pfizer Inc
|
69,850 | $1,681,988 | |
| 5 | LLY |
ELI LILLY & Co
|
800 | $959,544 | |
| 6 | NVO |
Novo Nordisk A S
|
16,000 | $767,040 | |
| 7 | OGN |
Organon & Co.
|
25,000 | $338,750 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $65,566,926 | 258,168 | Shares | Sole | 2026-07-01 | |
| 2026-03-31 | $63,106,585 | 258,168 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $53,365,782 | 257,868 | Shares | Sole | 2026-01-02 | |
| 2025-09-30 | $47,813,884 | 257,868 | Shares | Sole | 2025-10-01 | |
| 2025-06-30 | $39,389,337 | 257,868 | Shares | Sole | 2025-07-01 | |
| 2025-03-31 | $42,764,829 | 257,868 | Shares | Sole | 2025-04-01 | |
| 2024-12-31 | $37,292,870 | 257,868 | Shares | Sole | 2025-01-02 | |
| 2024-09-30 | $41,790,088 | 257,868 | Shares | Sole | 2024-10-02 | |
| 2024-06-30 | $37,689,986 | 257,868 | Shares | Sole | 2024-07-01 | |
| 2024-03-31 | $40,792,138 | 257,868 | Shares | Sole | 2024-06-03 | |
| 2023-12-31 | $40,120,424 | 255,968 | Shares | Sole | 2024-01-02 | |
| 2023-09-30 | $39,867,016 | 255,968 | Shares | Sole | 2023-10-04 | |
| 2023-06-30 | $42,367,823 | 255,968 | Shares | Sole | 2023-07-03 | |
| 2023-03-31 | $39,675,040 | 255,968 | Shares | Sole | 2023-04-04 | |
| 2022-12-31 | $45,216,747 | 255,968 | Shares | Sole | 2023-01-03 | |
| 2022-09-30 | $41,814,932 | 255,968 | Shares | Sole | 2022-10-03 | |
| 2022-06-30 | $45,436,879 | 255,968 | Shares | Sole | 2022-07-01 | |
| 2022-03-31 | $45,226,083 | 255,183 | Shares | Sole | 2022-04-01 | |
| 2021-12-31 | $43,174,304 | 252,378 | Shares | Sole | 2022-01-03 | |
| 2021-09-30 | $40,759,047 | 252,378 | Shares | Sole | 2021-10-01 | |
| 2021-06-30 | $42,824,657 | 259,953 | Shares | Sole | 2021-07-01 | |
| 2021-03-31 | $42,641,100 | 259,453 | Shares | Sole | 2021-04-01 | |
| 2020-12-31 | $40,678,795 | 258,475 | Shares | Sole | 2021-01-04 | |
| 2020-09-30 | $38,481,758 | 258,475 | Shares | Sole | 2020-10-01 | |
| 2020-06-30 | $36,349,339 | 258,475 | Shares | Sole | 2020-07-02 | |
| 2020-03-31 | $35,601,795 | 271,500 | Shares | Sole | 2020-04-01 | |
| No filing history on record for this holder in this stock. | ||||||